Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.18632/aging.103370 http://scihub22266oqcxt.onion/10.18632/aging.103370 32554861!7343487!32554861     free     free     free Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Aging+(Albany+NY) 2020 ; 12 (12): 11224-11237 Nephropedia Template TP {{tp|p=32554861|t=2020. Treatment strategies of hospitalized patients with coronavirus disease-19 |pdf=|usr=}}{{32554861}} gab.com Text Treatment strategies of hospitalized patients with coronavirus disease-19 JO: Aging (Albany NY) http://www.kidney.de/pget.php?&tw=1&pmid=32554861 #FOAvip With the outbreak of coronavirus disease-19 (COVID-19), Changsha faced an increasing burden of treating the Wuhan migrants and their infected patients. This study is a retrospective, single-center case series of the 238 consecutive hospitalized patients with confirmed COVID-19 at the First Hospital of Changsha city, China, from 01/21 to 02/14, 2020; the final date of follow-up was 02/27, 2020. Of 238 patients 43.7% visited Wuhan, 58.4% got in touch with Wuhan people, and 47.5% had contacted with diagnosed patients. 37.8% patients had family members infected. 190 cases had mild / general disease, and 48 cases had severe / critical disease. Compared to mild or general patients, more severe or critical patients visited Wuhan (59.6% vs 40.2%; P=0.02) and contacted with Wuhan people (74.5% vs 55.0%; P=0.02). All patients received antiviral treatment, including Lopinavir / Ritonavir (29.3%), Interferon (14.6%) and their combination (40.6%), Arbidol (6.7%), Xuebijing (7.1%) and Chloroquine phosphate (1.3%). Severe and critical patients received glucocorticoid, Gamma-globulin and oxygen inhalation. Some received mechanic ventilation support. As of 02/27, 161 patients discharged. The median length of hospital stay was 13 days. The 10-, 14-, 20- and 28-day discharge rate was 19.1%, 42.8%, 65.0% and 76.4%, respectively. No hospital-related transmission was observed. Twit Text FOAVip Treatment strategies of hospitalized patients with coronavirus disease-19 ????Aging (Albany NY) http://www.kidney.de/pget.php?&tw=1&pmid=32554861 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32554861 #FOAvip English Wikipedia <ref>{{Cite pmid|32554861}}</ref> Treatment strategies of hospitalized patients with coronavirus disease-19 #MMPMID32554861 Huang Y; Cai C; Zang J; Xie J; Xu D; Zheng F; Zhan T; Huang K; Wang Y; Wang X; Hu ZY; Deng Y; Xie Y Aging (Albany NY) 2020[Jun]; 12 (12): 11224-11237 PMID32554861show ga With the outbreak of coronavirus disease-19 (COVID-19), Changsha faced an increasing burden of treating the Wuhan migrants and their infected patients. This study is a retrospective, single-center case series of the 238 consecutive hospitalized patients with confirmed COVID-19 at the First Hospital of Changsha city, China, from 01/21 to 02/14, 2020; the final date of follow-up was 02/27, 2020. Of 238 patients 43.7% visited Wuhan, 58.4% got in touch with Wuhan people, and 47.5% had contacted with diagnosed patients. 37.8% patients had family members infected. 190 cases had mild / general disease, and 48 cases had severe / critical disease. Compared to mild or general patients, more severe or critical patients visited Wuhan (59.6% vs 40.2%; P=0.02) and contacted with Wuhan people (74.5% vs 55.0%; P=0.02). All patients received antiviral treatment, including Lopinavir / Ritonavir (29.3%), Interferon (14.6%) and their combination (40.6%), Arbidol (6.7%), Xuebijing (7.1%) and Chloroquine phosphate (1.3%). Severe and critical patients received glucocorticoid, Gamma-globulin and oxygen inhalation. Some received mechanic ventilation support. As of 02/27, 161 patients discharged. The median length of hospital stay was 13 days. The 10-, 14-, 20- and 28-day discharge rate was 19.1%, 42.8%, 65.0% and 76.4%, respectively. No hospital-related transmission was observed. |*Betacoronavirus[MESH] |*Respiration, Artificial[MESH] |Adult[MESH] |Anti-Inflammatory Agents, Non-Steroidal/therapeutic use[MESH] |Antiviral Agents/*therapeutic use[MESH] |COVID-19[MESH] |China/epidemiology[MESH] |Chloroquine/analogs & derivatives/therapeutic use[MESH] |Coronavirus Infections/*epidemiology/*therapy[MESH] |Drug Combinations[MESH] |Drugs, Chinese Herbal/therapeutic use[MESH] |Female[MESH] |Glucocorticoids/therapeutic use[MESH] |Hospitalization[MESH] |Humans[MESH] |Immunologic Factors/therapeutic use[MESH] |Indoles/therapeutic use[MESH] |Interferons/therapeutic use[MESH] |Lopinavir/therapeutic use[MESH] |Male[MESH] |Middle Aged[MESH] |Oxygen/therapeutic use[MESH] |Pandemics[MESH] |Pneumonia, Viral/*epidemiology/*therapy[MESH] |Retrospective Studies[MESH] |Ritonavir/therapeutic use[MESH] |SARS-CoV-2[MESH]Treatment strategies of hospitalized patients with coronavirus disease(epmc).pdf DeepDyve Pubget Overpricing